Which is better, RDNT or TMO?

On the Buffett-Fit framework, Thermo Fisher Scientific Inc. (TMO) currently grades higher than RDNT — 52/100 (C grade) vs 27/100 (F). That said, "better" depends on which framework you trust — RDNT wins on Peter Lynch; TMO wins on Warren Buffett, Benjamin Graham, Philip Fisher, Joel Greenblatt, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy RDNT or TMO?

This page is an educational comparison, not investment advice. Both RDNT and TMO are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is RDNT better than TMO for value investing?

On the Buffett-style value-investing framework, TMO currently grades higher — 52/100 vs 27/100, a 25-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between RDNT and TMO on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). RDNT currently scores 27/100 (F grade); TMO scores 52/100 (C grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, RDNT or TMO?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. RDNT and TMO are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, RDNT or TMO?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are RDNT and TMO both Healthcare stocks?

Yes — both RadNet, Inc. (RDNT) and Thermo Fisher Scientific Inc. (TMO) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this RDNT vs TMO comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

RadNet

RDNT

Market cap

$4.27B

Sector

Healthcare

Overall winner

Thermo Fisher Scientific

RDNT 1–6 TMO

Thermo Fisher Scientific

TMO

Market cap

$175.7B

Sector

Healthcare

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

Fit scores by strategy

RDNTvsTMO

Warren Buffett

27F

52C

Benjamin Graham

51D

74B

Philip Fisher

32F

40D

Peter Lynch

42D

28F

Joel Greenblatt

40D

51D

Charlie Munger

28F

52D

Terry Smith

21F

45D

Side-by-side metrics

Metric	RDNT	TMO
Market cap	$4.27B	$175.7B
P/E (TTM)	-	26.4x
EV/EBIT	63.4x	27.2x
ROIC (TTM)	1.61%	7.33%
Gross margin	9.22%	39.41%
Net margin	-0.66%	15.18%
Revenue CAGR 5y	11.6%	3.25%
EPS CAGR 5y	-	-2.43%
Debt / Equity	1.8x	0.8x
Dividend yield	0.0%	0.36%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

RDNT leads on

P/E (TTM)-vs 26.4x+109%
Revenue CAGR 5y11.6%vs 3.25%+72%

TMO leads on

Net margin15.18%vs -0.66%+104%
Dividend yield0.36%vs 0.0%+100%
Market cap$175.7Bvs $4.27B+98%
ROIC (TTM)7.33%vs 1.61%+78%

More like RDNT

RDNT vs JSLL.NS RDNT vs JSLL.BO RDNT vs 4728.TWO RDNT vs CAMX.ST RDNT vs PME.AX RDNT vs HALO

More like TMO

TMO vs JSLL.NS TMO vs JSLL.BO TMO vs 4728.TWO TMO vs CAMX.ST TMO vs PME.AX TMO vs HALO

Read the full Buffett-Brain analysis for RDNT Read the full Buffett-Brain analysis for TMO

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Stock comparison

RadNet

RDNT

Market cap

$4.27B

Sector

Healthcare

Overall winner

Thermo Fisher Scientific

RDNT 1–6 TMO

Thermo Fisher Scientific

TMO

Market cap

$175.7B

Sector

Healthcare

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

Fit scores by strategy

RDNTvsTMO

Warren Buffett

27F

52C

Benjamin Graham

51D

74B

Philip Fisher

32F

40D

Peter Lynch

42D

28F

Joel Greenblatt

40D

51D

Charlie Munger

28F

52D

Terry Smith

21F

45D

Side-by-side metrics

Metric	RDNT	TMO
Market cap	$4.27B	$175.7B
P/E (TTM)	-	26.4x
EV/EBIT	63.4x	27.2x
ROIC (TTM)	1.61%	7.33%
Gross margin	9.22%	39.41%
Net margin	-0.66%	15.18%
Revenue CAGR 5y	11.6%	3.25%
EPS CAGR 5y	-	-2.43%
Debt / Equity	1.8x	0.8x
Dividend yield	0.0%	0.36%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

RDNT leads on

P/E (TTM)-vs 26.4x+109%
Revenue CAGR 5y11.6%vs 3.25%+72%

TMO leads on

Net margin15.18%vs -0.66%+104%
Dividend yield0.36%vs 0.0%+100%
Market cap$175.7Bvs $4.27B+98%
ROIC (TTM)7.33%vs 1.61%+78%

More like RDNT

RDNT vs JSLL.NS RDNT vs JSLL.BO RDNT vs 4728.TWO RDNT vs CAMX.ST RDNT vs PME.AX RDNT vs HALO

More like TMO

TMO vs JSLL.NS TMO vs JSLL.BO TMO vs 4728.TWO TMO vs CAMX.ST TMO vs PME.AX TMO vs HALO

Read the full Buffett-Brain analysis for RDNT Read the full Buffett-Brain analysis for TMO

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.